Maleimide end-functionalized poly(2-oxazoline)s by the functional initiator route: synthesis and (bio)conjugation by Gil Alvaradejo, Gabriela et al.
RSC Advances
PAPER
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 0
5 
M
ar
ch
 2
01
8.
 D
ow
nl
oa
de
d 
on
 2
2/
05
/2
01
8 
11
:1
7:
17
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e. View Article Online
View Journal  | View IssueMaleimide end-faInstitute of Toxicology and Genetics (ITG),
Hermann-von-Helmholtz-Platz 176344, Egg
guillaume.delaittre@kit.edu
bMacromolecular Architectures, Institute
Chemistry (ITCP), Karlsruhe Institute of Tec
cSupramolecular Chemistry Group, Depar
Chemistry, Ghent University, Krijgslaan 281
† Electronic supplementary informa
10.1039/c8ra00948a
Cite this: RSC Adv., 2018, 8, 9471
Received 30th January 2018
Accepted 22nd February 2018
DOI: 10.1039/c8ra00948a
rsc.li/rsc-advances
This journal is © The Royal Society of Cunctionalized poly(2-oxazoline)s
by the functional initiator route: synthesis and (bio)
conjugation†
Gabriela Gil Alvaradejo,ab Mathias Glassner,c Richard Hoogenboom c
and Guillaume Delaittre *ab
The synthesis of poly(2-ethyl-2-oxazoline)s with a maleimide group at the a chain end was carried out from
new sulfonate ester initiators bearing a furan-protected maleimide group. The conditions of the
polymerization were optimized for 50 C using conventional heating (in contrast to microwave
irradiation) to counteract the thermal lability of the cycloadduct introduced to protect the maleimide
double bond. At this temperature, a tosylate variant was found to be unable to initiate the polymerization
after several days. The controlled polymerization of 2-ethyl-2-oxazoline with a nosylate derivative was,
however, successful as shown by kinetic experiments monitored by gas chromatography (GC) and size-
exclusion chromatography (SEC). Poly(2-ethyl-oxazoline)s of various molar masses (4500 < Mn <
12 000 g mol1) with narrow dispersity (Đ < 1.2) were obtained. The stability of the protected maleimide
functionality during the polymerization, its deprotection, and the reactivity of the deprotected end group
by coupling with a model thiol molecule were proven by 1H NMR spectroscopy and electrospray
ionization mass spectrometry (ESI-MS). Finally, the conjugation of maleimide-functionalized poly(2-
oxazoline) to a model protein (bovine serum albumin) was demonstrated by gel electrophoresis and
MALDI-ToF mass spectrometry.Introduction
The synthesis of poly(2-alkyl/aryl-2-oxazoline)s (PAOx) by poly-
merization of 2-oxazolines was rst described in the 1960s.1–4
However, it is only in recent years that interest in these polymers
has strongly increased, thanks to their potential in biomedical
applications5–7 and the thermoresponsive properties of certain
PAOx.8 Particularly, poly(2-methyl-2-oxazoline) (PMeOx) and
poly(2-ethyl-2-oxazoline) (PEtOx) share properties such as
biocompatibility, low toxicity, and antifouling behavior with
poly(ethylene glycol) (PEG), the gold standard for stealth poly-
mers.9,10 The most important advantage of these PAOx over PEG
is that their synthesis does not require a complex experimental
setup (e.g., no handling of gaseous monomer), while allowing
the tailoring of the functionalities at the chain ends or the side
chains through the substituent at the 2-position of the 2-oxa-
zoline ring.11 In addition, there is an increasing concernKarlsruhe Institute of Technology (KIT),
enstein-Leopoldshafen, Germany. E-mail:
for Chemical Technology and Polymer
hnology (KIT), 76128 Karlsruhe, Germany
tment of Organic and Macromolecular
S4, 9000 Ghent, Belgium
tion (ESI) available. See DOI:
hemistry 2018regarding the use of PEG in some life sciences applications due
to its degradation mode12,13 and potential immunogenicity.14,15
Polymerization of 2-oxazolines can proceed, under appro-
priate conditions, via a living cationic ring-opening (CROP)
mechanism, which results in a controlled length of the polymer,
narrow molar mass distributions, and the introduction of
specic end groups by initiation and termination.16 Taking
advantage of the CROP mechanism, several functionalization
strategies of PAOx are available (Scheme 1).11,17 Besides specic
monomer design, end-functionalized PAOx can be obtained
using functional initiators and terminating agents.18 While
many reports on end functionalization are based on a termi-
nating strategy, the use of functional initiators may be more
convenient in terms of stoichiometry – 1 functional initiator
molecule ideally leads to 1 polymeric chain – while terminating
agents are usually introduced in (large) excess. Common initi-
ators for CROP are alkyl halides,19,20 or alkyl sulfonates,
including tosylates,21 nosylates,22 and triates.21 A number of
initiators that add a specic functionality to the polymeric
chain or allow further functionalization have been reported.
Among these functionalities are allyl,23 amine,24 hydroxyls,25 or
carboxylic acid,26 sometimes requiring protecting group
strategies.26
In this work, our aim is to develop a strategy for the intro-
duction of a maleimide moiety at the a chain end of PAOx (see
Scheme 1). The maleimide moiety can undergo radicalRSC Adv., 2018, 8, 9471–9479 | 9471
Scheme 1 General strategies for the functionalization of PAOx and
aim of the current work.
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View Article Onlinecopolymerization27 and may engage in a range of coupling
reactions, including Diels–Alder reactions,28–31 dipolar cycload-
ditions,32 and Michael-type additions.33 This versatility makes it
a suitable group for post-polymerization modication (PPM),
protein conjugation, synthesis of block copolymers, (reversible)
network formation, or surface functionalization. Some exam-
ples of maleimide end-functionalized polymers have been re-
ported,34–38 including poly(2-oxazoline)s. In the latter case,
Schacher and co-workers introduced the maleimide end group
by PPM at the u chain end, by rst capping with sodium azide
and then performing azide–alkyne cycloaddition with an
alkyne-functionalized protected maleimide, which had been
synthesized in three steps with an overall yield of 9%, including
a column chromatography step.37 A second approach to add
a maleimide functionality at the u chain end was recently re-
ported by Luxenhofer and co-workers,38 where furan-protected
maleimide was directly used as terminating agent for the
CROP of AOx. The capping agent was obtained without complex
purication, in a single step with a yield of 45%. Yet, the
termination eﬃciency was reported to be 55%, and it was fol-
lowed by a deprotection step (approx. 85%) to yield the
maleimide-bearing PAOx. Using a functional initiator to intro-
duce the maleimide at the a chain end oﬀers an interesting
alternative, as the maleimide moiety – provided no transfer
reactions occur – will be present in all chains from the start,
while giving a new possibility of creating maleimide-based
bifunctional (hetero)telechelic PAOx by terminating the reac-
tion with a functional nucleophile. In the current study, we
present the straightforward synthesis of novel maleimide-
containing CROP initiators and their application to the
synthesis of a-maleimido-PAOx. We nally demonstrate the
reactivity of the maleimide end group in small molecule
coupling as well as in the formation of protein–PAOx conjugates.Experimental section
Materials
Maleic anhydride (99%, Bernd Kra), furan (99%, Acros), etha-
nolamine (99%, Acros), 4-toluenesulfonyl chloride (99%, Acros), 4-
nitrobenzenesulfonyl chloride (97%, Sigma-Aldrich), pyridine
(99%, Roth), tetramethylammonium hydroxide (25 wt% in
methanol, Acros), bovine serum albumin (BSA; Sigma), toluene
(Fisher), petroleum ether (Acros), ethanol (99.8%, Acros), acetone
(Fisher), tetrahydrofuran (THF; VWR), diethyl ether (99.5%, Roth),9472 | RSC Adv., 2018, 8, 9471–9479and dichloromethane (DCM; VWR) were used as received. Aceto-
nitrile (MeCN; Sigma-Aldrich) was dried in a solvent purication
system (JC Meyer) before use as a polymerization solvent. 2-Ethyl-
2-oxazoline (EtOx; Aldrich) was distilled over barium oxide and
stored under argon.General characterization
All polymer solutions and samples were prepared in a VIGOR
Sci-Lab SG 1200/750 Glovebox System with a water concentra-
tion #0.1 ppm.
Gas chromatography (GC). Gas chromatography (GC) was
carried out on a 7890A from Agilent Technologies with an Agi-
lent J&W Advanced Capillary GC column (30 m, 0.320 mm, and
0.25 lm). Injections were operated with an Agilent Technologies
7693 auto sampler.
1H nuclear magnetic resonance (NMR) spectroscopy. 1H
nuclear magnetic resonance (NMR) spectroscopy measure-
ments were performed on a Bruker AM 500 spectrometer
(500 MHz). All compounds were dissolved in either CDCl3 or
DMSO-d6 and the residual solvent peak was employed for shi
correction (7.26 ppm for CDCl3 and 2.50 ppm for DMSO-d6).
Size-exclusion chromatography (SEC). Size-exclusion chro-
matography (SEC) with N,N-dimethylacetamide (DMAc) con-
taining 0.03 wt% LiBr as eluent was accomplished at a ow rate
of 1 mL min1 with a sample concentration of 2 g L1 on
a Polymer Laboratories PL-GPC 50 Plus Integrated system
comprising an autosampler, a PLgel 5.0 mm bead-size guard
column (50 mm  7.5 mm) followed by three PLgel 5 mm Mix-
edC columns (300 mm  7.5 mm) and a diﬀerential refractive
index detector. The SEC system was calibrated against linear
poly(methyl methacrylate) standards with molar masses
ranging from 700 to 2  106 Da. The samples were ltered
through PTFE membranes with a pore size of 0.2 mm prior to
injection. To obtain Mn and Đ values, the integration of the
polymer peak was carried out from low elution times to
approximately 33 minutes due to overlap with an SEC system
peak. No baseline correction was performed. Consequently, Mn
and Đ values can be considered as estimates. Nevertheless,
values at high conversions are fairly accurate since minimal
overlap is observed.
Electrospray ionization mass spectrometry (ESI-MS). Spectra
were recorded on an LXQ mass spectrometer (Thermo Fisher
Scientic, San Jose, CA) equipped with an atmospheric pressure
ionization source operating in the nebulizer assisted electro-
spray mode. The instrument was calibrated in the m/z range
195–1822 using a standard containing caﬀeine, Met-Arg-Phe-Ala
acetate (MRFA), and a mixture of uorinated phosphazenes
(Ultramark 1621) (all from Aldrich). A constant spray voltage of
4.5 kV was used. Nitrogen at a dimensionless sweep gas ow
rate of 2 (approximately 3 L min1) and a dimensionless sheath
gas ow rate of 5 (approximately 0.5 L min1) was applied. The
capillary voltage, the tube lens oﬀset voltage, and the capillary
temperatures were set to 34 V, 90 V, and 275 C, respectively.
The samples were dissolved at a concentration of 0.1 mg mL1
in a mixture of THF and MeOH (3 : 2 v/v) containing sodium
triuoroacetate (0.14 mg L1).This journal is © The Royal Society of Chemistry 2018
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View Article OnlineSodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE). Sodium dodecyl sulfate polyacrylamide gel elec-
trophoresis (SDS-PAGE) was used to analyze protein–polymer
conjugates on 12% SDS-PAGE under non-reducing conditions,
using standard molecular biology techniques, followed by
Coomassie Brilliant Blue staining.
Fast protein liquid chromatography (FPLC). Fast protein
liquid chromatography (FPLC) was performed for the prepara-
tive separation of BSA conjugates. An A¨TKA purier system
equipped with an autosampler A-905 and a Fraction Collector
Frac-950 (GE Healthcare, Sweden) was used. The separation of
BSA–PEtOx conjugates was performed on a Superdex 200 10/300
GL (GE Healthcare, Uppsala, Sweden) SEC column using
a 0.05 M phosphate buﬀer (pH 7.0) and 0.15 M NaCl solution.
The column was loaded with 300 mL of sample and the system
was run at a ow rate of 0.5 mL min1. Fractions of 250 mL were
collected into a 96-well deep well plate (VWR, Radnor, PA, USA).
A UV detector continuously measured the relative absorbance of
the mobile phase at 280 nm. The yields were not optimized.
Matrix-assisted laser desorption ionization coupled to time-
of-ight (MALDI-ToF) mass spectra. Matrix-assisted laser
desorption ionization coupled to time-of-ight (MALDI-ToF)
mass spectra were acquired with a 4800 Proteomics Analyzer
(Applied Biosystems, Foster City, CA, USA) in positive ion linear
mode and a mass range of 60 000 to 80 000 Da. The laser
intensity was set to 4700. The spectra obtained represent the
average of laser shots taken by an automatic scheme measuring
spectra over the whole spot.Synthesis of maleimide-functionalized initiators
3a,4,7,7a-Tetrahydro-4,7-epoxyisobenzofuran-1,3-dione (1).
Maleic anhydride (30.0 g, 306 mmol) was suspended in toluene
(150 mL) in a 250 mL round-bottom ask. This mixture was
heated to 80 C. Furan (33.4 mL, 459mmol) was added dropwise
with a syringe. Aer stirring for 6 h, the mixture was cooled to
ambient temperature and then le in the freezer overnight. The
resulting crystals were collected by ltration and washed with
petroleum ether (3  30 mL). 1 was obtained as white crystals
aer drying under reduced pressure (41.7 g, 82%).
1H NMR (CDCl3, 500 MHz, d): 6.58 (s, 2H), 5.47 (s, 2H), 3.18
(s, 2H) ppm.
2-(2-Hydroxyethyl)-3a,4,7,7a-tetrahydro-1H-4,7-epoxyisoindole-
1,3(2H)-dione (2). The anhydride 1 (10.0 g, 60.2 mmol) was
dissolved in ethanol (15 mL) in a 100 mL two-neck round-
bottom ask. A solution of ethanolamine (3.75 mL, 62.1
mmol) in ethanol (5 mL) was added dropwise. The resulting
solution was stirred and heated under reux for 4 h. Subse-
quently, the solution was kept at 20 C overnight. The
white solid obtained was ltered, recrystallized in ethanol, and
dried under reduced pressure to yield 2 as a white powder
(4.34 g, 34%).
1H NMR (CDCl3, 500 MHz, d): 6.53 (s, 2H), 5.29 (s, 2H), 3.76–
3.79 (m, 2H), 3.70–3.72 (m, 2H), 2.90 (s, 2H) ppm.
2-(1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-
2-yl)ethyl 4-methylbenzenesulfonate (FurMalTos 3). A solution
of compound 2 (1.0 g, 4.8 mmol) and pyridine (0.75 g, 9.5 mmol)This journal is © The Royal Society of Chemistry 2018in THF (7 mL) was prepared in a 50 mL round-bottom ask
cooled to 0 C, before a solution of 4-toluenesulfonyl chloride
(1.82 g, 9.5 mmol) in THF (5 mL) was added to it in a dropwise
fashion. The mixture was then stirred at ambient temperature
overnight. The remaining solution was ltered and the solvent
was removed under reduced pressure. The product was dis-
solved in DCM and the mixture was washed with saturated
NaHCO3 and water, before being dried over MgSO4. The solvent
was removed under vacuum and the residual white powder was
recrystallized in an ethanol/acetone mixture (2 : 1 v/v). Aer
ltration and drying under reduced pressure, 3 was obtained as
white crystals (1.10 g, 63%).
1H NMR (CDCl3, 500 MHz, d): 7.75–7.73 (d, 2H), 7.31–7.33 (d,
2H), 6.50 (s, 2H), 5.22 (s, 2H), 4.17 (t, 2H), 3.73 (t, 2H), 2.84 (s,
2H), 2.42 (s, 3H) ppm.
13C NMR (CDCl3, 125 MHz, d): 21.75, 37.77, 47.63, 65.51,
80.94, 128.05, 129.99, 132.74, 136.61, 145.15, 175.86 ppm.
ESI-MS (m/z): [M  Na+] calc.: 386.067, found: 386.066 amu.
2-(1,3-Dioxo-1,3,3a,4,7,7a-hexahydro-2H-4,7-epoxyisoindol-
2-yl)ethyl 4-nitrobenzenesulfonate (FurMalNos 4). A solution of
compound 2 (1.0 g, 4.8 mmol) and pyridine (0.75 g, 9.5 mmol) in
THF (7 mL) prepared in a 50 mL round-bottom ask was cooled
to 0 C. To this, a solution of 4-nitrobenzenesulfonyl chloride
(2.12 g, 9.5 mmol) in THF (5 mL) was added dropwise. The
mixture was then stirred at ambient temperature overnight,
aer which the produced solid was ltered. The obtained solid
was dissolved in DCM, washed with saturated NaHCO3 and
water, before being dried over MgSO4. Aer ltering oﬀ the
drying agent, the solvent was removed. The residual white
powder was recrystallized in an acetone/methanol mixture (3 : 1
v/v). Aer ltration and drying under reduced pressure, 4 was
recovered as a white powder (0.55 g, 29%).
1H NMR (CDCl3, 500 MHz, d): 8.38–8.40 (d, 2H), 8.09–8.11 (d,
2H), 6.52 (s, 2H), 5.24 (s, 2H), 4.32 (t, 2H), 3.80 (t, 2H), 2.88 (s,
2H) ppm.
13C NMR (CDCl3, 125 MHz, d): 37.09, 47.11, 67.49, 80.35,
125.04, 129.32, 136.47, 140.11, 150.78, 176.12 ppm.
ESI-MS (m/z): [M  Na+] calc.: 417.036, found: 417.035 amu.Cationic ring-opening polymerization of 2-ethyl-2-oxazoline
The furan-protected maleimide initiators were dissolved in
MeCN in glass vials at diﬀerent monomer-to-initiator ratios
([M]/[I] ¼ 20, 40, and 60) at a monomer concentration of 1.5 M.
The vials were capped under inert conditions in a glove box.
The capped vials were heated to 50 C with constant stirring
under inert atmosphere. Samples for GC and SEC analysis
were taken periodically using a syringe, quenched by the
addition of water, and injected without further purication in
order to monitor kinetics and molar mass distributions. For
further experiments, the polymerization was terminated by
addition of tetramethylammonium hydroxide.39 Aer evapo-
ration of the solvent under reduced pressure and dissolving
the residue in DCM, the polymer was precipitated in diethyl
ether, centrifuged, separated, and dried under vacuum. The
dry product was analyzed by DMAc SEC, ESI-MS, and 1H NMR
spectroscopy.RSC Adv., 2018, 8, 9471–9479 | 9473
Scheme 2 Synthetic route for maleimide-functionalized tosylate and
nosylate initiators for the CROP of 2-oxazolines.
Scheme 3 Synthetic route for the synthesis of a-maleimido-PEtOx by
polymerization of EtOx using functional initiators 3 and 4 and retro-
Diel–Alder cycloelimination, followed by Michael addition with
a model small molecule.
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View Article OnlineDeprotection of the maleimide end group (Mal-PEtOx)
In a 25 mL round-bottom ask, 100 mg of a furan-protected
maleimide end-functionalized polymer FurMal-PEtOx
(Mn,SEC ¼ 6500 g mol1, Đ ¼ 1.20, Mn,NMR ¼ 4400 g mol1) was
dissolved in toluene (10 mL). This solution was then heated to
110 C for 4 h. Aer evaporation of the solvent under reduced
pressure and dissolving the residue in DCM, the product was
precipitated in diethyl ether, centrifuged, separated, and dried
under vacuum. The dry product Mal-PEtOx was analyzed by
DMAc SEC, ESI-MS, and 1H NMR spectroscopy.
Model Michael addition with benzyl mercaptan
In a 25 mL round-bottom ask, deprotected Mal-PEtOx (30 mg)
was dissolved in DCM (10 mL), then mixed with a 10-fold excess
of benzylmercaptan and 0.1 equivalent of triethylamine. The
mixture was stirred overnight at room temperature. Aer
evaporation of the solvent under reduced pressure and dis-
solving the residue in DCM, the product was precipitated in
diethyl ether, centrifuged, separated, and dried under vacuum.
The dry product was analyzed by ESI-MS and 1H NMR
spectroscopy.
Bioconjugation with BSA
Three solutions of diﬀerent polymer-to-protein molar ratios
were prepared (5, 10, and 15). A solution of 100 mM PBS was
degassed by bubbling nitrogen for 30 min. 3 mL of oxygen-free
water was transferred via a degassed syringe into a sealed vial
equipped with a rubber septum, containing 40 mg of BSA and
either 18.75, 37.5, or 56.5 mg of MalPEtOx (Mn,SEC ¼ 10 600 g
mol1, Đ ¼ 1.13, Mn,NMR ¼ 5500 g mol1) stored under
a nitrogen atmosphere. Aer 18 h, several aliquots were taken
for SDS-PAGE. For the sample with the polymer-to-protein ratio
of 5 : 1, preparative FPLC was carried out and a relevant fraction
was analyzed by MALDI-ToF mass spectrometry.
Results and discussion
Synthesis of protected maleimide initiators
Protection of the maleimide is necessary during CROP to avoid
nucleophilic attacks and other potential side reactions. In the
current study, it was decided to employ alkyl sulfonate-type
initiators because they typically lead to faster polymerizations
via exclusive cationic propagation21 and are readily synthesized
from alcohol derivatives in one step, typically with purication
by simple recrystallization.40 While tosylate derivatives are
signicantly more popular, the utility of nosylate initiators was
recently demonstrated.41 Here, both types of sulfonates were
synthesized and characterized for the CROP of 2-ethyl-2-
oxazoline. Scheme 2 depicts the synthetic strategy followed to
obtain the initiators. In this contribution, maleic anhydride is
used as the starting material to incorporate the activated ene
group. Prior to further functionalization, the latter was pro-
tected through a classic Diels–Alder cycloaddition with furan.
The cycloadduct 1 was subsequently ring-opened with etha-
nolamine and dehydrated, to yield the hydroxylated N-
substituted protected maleimide 2. The corresponding tosylate9474 | RSC Adv., 2018, 8, 9471–94793 and nosylate 4 were nally obtained by nucleophilic substi-
tution of 2 with tosyl and nosyl chloride, respectively. The
overall yields for these 3-step syntheses were of 17.5 and 8.1%,
for 3 and 4, respectively. It is to note that the starting materials
are extremely cheap and that no chromatographic step is
required throughout the entire synthesis, in contrast to the
aforementioned synthetic strategies for maleimide end-
functional PEtOx (vide supra).37,38 Analysis of both initiators by
1H and 13C NMR spectroscopy, as well as ESI-MS conrmed that
the targeted structures were obtained with high purity (Fig. S1–
S6†). Dissolution tests revealed a limited solubility for the
nosylate initiator (FurMalNos 4) in MeCN, the most commonly
employed solvent for the CROP of 2-oxazolines.
Polymerization
Our interest was to produce water-soluble poly(2-oxazoline)s
with a view on applications in life sciences, such as anti-
fouling surface treatment and protein conjugation. In the
current study, 2-ethyl-2-oxazoline (EtOx) was chosen as the
monomer (Scheme 3). Despite a lower water-solubility due to
the existence of an LCST at approx. 60 C, PEtOx is usually moreThis journal is © The Royal Society of Chemistry 2018
Fig. 1 (A) First-order kinetic plots and (B) evolution of the number-
averagemolarmass and dispersity vs. conversion for the CROP of EtOx
initiated by FurMalNos 4 at various targeted degrees of polymerization
(DP ¼ [EtOx]/[FurMalNos]) in MeCN at 50 C. [EtOx] ¼ 1.5 M. Please
refer to Fig. S11–S13† for corresponding SEC traces.
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View Article Onlineconvenient than PMeOx which possesses a low solubility in
other solvents, including in the monomer itself.34 It has been
reported that very fast CROP of various 2-oxazolines, including
EtOx, can be achieved by microwave-assisted polymerization in
acetonitrile at 140 C.42However, such a high temperature is not
suitable here as it would lead to deprotection of the maleimide
group by cycloelimination. Therefore, signicantly lower
temperatures were directly employed for the preliminary
experiments. Unfortunately, microwave-assisted polymerization
at 80 C was found to already trigger the loss of the maleimide
protecting group (Fig. S7†). In addition, polymerization tests
carried out at 80 C using conventional heating showed broader
molar mass distributions (Đ ¼ 1.32–1.41), indicating the loss of
control over the polymerization (Fig. S8†). Consequently, to
prevent the deprotection of the maleimide group and favor
a controlled polymerization, the polymerization temperature
was further lowered to 50 C using conventional heating.
A rst set of kinetics of EtOx polymerization was carried out
in MeCN with [EtOx] ¼ 4 M, in the case of FurMalTos 3, and
[EtOx] ¼ 1.5 M for FurMalNos 4. The latter monomer concen-
tration is signicantly lower than what is typically encountered
in the literature,43 due to the aforementioned limited solubility
of FurMalNos 4 in MeCN. It has been previously reported that
optimum monomer concentrations are usually established
around 4 M.43
An initial assessment of the ability of the two new protected
maleimide-functionalized sulfonic esters to initiate the poly-
merization at 50 C was carried out by targeting a degree of
polymerization (DP) of 50 at full conversion, that is [EtOx]/
[initiator] ¼ 50. Aer 74 hours, a conversion of 72% was ach-
ieved with the FurMalNos 4, whereas for the FurMalTos 3 less
than 10% was obtained (Fig. S9†). In a recent study on CROP of
2-oxazolines in MeCN at 80 C, it was reported that, apart from
methyl tosylate, initiation with alkyl tosylates typically leads to
slow initiation and low propagation rates due to low electro-
philicity and relatively low leaving group ability, respectively.41
However, the reactivity of ethyl nosylate is suﬃciently high to
quantitatively initiate in the rst instants of the polymerization.
Therefore, subsequent investigations were exclusively conduct-
ed with FurMalNos 4 as initiator. Importantly, at the end of the
polymerization, the survival of the furan-maleimide cyclo-
adduct could be observed by 1H NMR spectroscopy (Fig. 2).
Further polymerizations varying monomer-to-initiator ratios
were carried out in order to evaluate the possibility of producing
a-maleimido-PEtOx of various molar masses (Fig. 1). As previ-
ously observed,21 with all other parameters remaining constant,
the lower the monomer-to-initiator ratio, the faster the poly-
merization (Fig. 1A). All kinetics exhibited a similar trend, i.e.,
a rather slow polymerization with two distinct regimes: (i) a slow
non-linear increase of ln(1/(1  conversion)) with time at the
beginning of the polymerization and (ii) a linear behavior
indicating a constant concentration of propagating species. The
kp values corresponding to this second regime are collated in
Table S1† and appear to be independent of the initial monomer-
to-initiator concentration, as observed in previous studies.21
The two-stage nature of the polymerization can be explained by
a relatively slow initiation reaction resulting in a slow build-upThis journal is © The Royal Society of Chemistry 2018of the concentration of propagating species. In comparison to
previously reported polymerizations, which were initiated with
a nosylate of similar structure (ethyl nosylate) and did not
exhibit slow initiation,41 this phenomenon can certainly be
attributed to the diﬀerent polymerization conditions (lower
temperature and monomer concentration).
Satisfactorily, with increasing conversion, all SEC traces
shied progressively towards lower retention times (Fig. S11–
S13†) and number-average molar masses (Mn) increased line-
arly, while dispersity values remained conned between 1.1 and
1.2 (Fig. 1B), pointing at a polymerization with living character.
This demonstrates that FurMalNos enables the synthesis of
well-dened polymers despite the slow initiation reaction. The
fact that the molar masses are signicantly higher than the
theoretical ones further underpins the slow initiation reaction.
However, it should be noted that the discrepancy between
theoretical and experimental Mn values is also due to the fact
that the latter are calculated relative to poly(methylRSC Adv., 2018, 8, 9471–9479 | 9475
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View Article Onlinemethacrylate) standards which results in an overestimation.44
1H NMR spectroscopy was used to calculate molar masses for
nal samples, aer purication. The end group signals from the
protected maleimide moiety found at 5.2 and 6.5 were consid-
ered and compared to those corresponding to the side chain
and backbone of the PEtOx (Fig. 2A).
In contrast to the SEC results, the values obtained were
signicantly closer to the theoretical ones. For instance, for a a-
furan-maleimide-PEtOx sample prepared with [EtOx]/[FurMal-
Nos] ¼ 40, aer 78% conversion,Mn,SEC ¼ 10 600 g mol1 while
Mn,NMR ¼ 6100 g mol1. This latter value, although signicantly
closer, is still higher than the theoretical value. This fact may
corroborate the slow initiation which would result in a higher
eﬀective monomer-to-initiator ratio throughout a signicant
part of the polymerization. Yet, the linear trend observed aer
40 hours of polymerization in all cases suggests another cause.
The diﬀerence between the expected and NMR calculated
degrees of polymerization of the resulting polymer would lead
to an initiator eﬃciency of 53% or more. We can assume that
non-negligible chain transfer occurs, leading to new chains
which do not carry the functional group. However, for many
applications, e.g., surface functionalization, this would not be
an issue, as non-reactive polymer can be easily washed away.
Deprotection and reactivity assessment
A polymer FurMal-PEtOx obtained (Mn,SEC ¼ 6500 g mol1, Đ ¼
1.20;Mn,NMR¼ 4400 gmol1) was puried to conrm the nature
of the end groups and was subsequently employed for coupling
reactions. 1H NMR spectroscopy and ESI-MS were used to assess
the stability of the furan-protected maleimide throughout theFig. 2 NMR spectra of a poly(2-ethyl-2-oxazoline) FurMal-PEtOx obtai
6500 g mol1, Đ ¼ 1.20; Mn,NMR ¼ 4400 g mol1 before (A) and a
cycloelimination.
9476 | RSC Adv., 2018, 8, 9471–9479polymerization and to allow the monitoring of further modi-
cations (Fig. 2 and 3). The 1H NMR spectrum of FurMal-PEtOx
displays the expected peaks for the 6 methine protons (e–g) of
the furan-maleimide Diels–Alder cycloadduct (Fig. 2A).
Furthermore, no signal corresponding to vinyl protons of
deprotected maleimide could be found (expected d at approx.
6.7 ppm). The stability of the protecting group was further
corroborated by ESI-MS with the presence of a major population
corresponding to chains possessing the initiating group and
a hydroxyl moiety as end groups (Fig. 3A and S14†). The only
major side-product is a proton-initiated PEtOx (see Fig. S14† for
full assignment), which is seen in most PAOx reports and
originates from a chain transfer reaction via b-elimination.45
Straightforward thermal treatment in solution at 110 C for
4 h yielded the deprotected a-functional Mal-PEtOx. As shown
in the 1H NMR spectrum, the characteristic oxanorbornene
signals of the cycloadduct quantitatively vanished (Fig. 2B),
leaving new peaks (e') corresponding to vinylic protons of an
electron-decient structure. The quantitative survival of the
maleimide group is evident from the similar integration values
obtained from the corresponding signals. To assess chain-end
transformation, mass spectrometry is one of the most potent
methods. While the original peaks assigned to FurMal-PEtOx
disappeared, a new set of peaks with an unambiguous shi of
about 34 amu (doubly charged species) corresponding to the
loss of a furan molecule was observed aer thermal treatment,
with essentially no by-product (Fig. 3B and S14†).
The reactivity of the maleimide group ofMal-PEtOx was then
assessed by Michael addition with a model thiol (benzyl
mercaptan), catalyzed by triethylamine. Again, the peakned through FurMalNos initiation ([EtOx]/[FurMalNos]) ¼ 20; Mn,SEC ¼
fter (B) deprotection of the maleimide group by retro-Diels–Alder
This journal is © The Royal Society of Chemistry 2018
Fig. 3 ESI-MS spectra of (A) FurMal-PEtOx as obtained after CROP of EtOx initiated by FurMalNos, (B) Mal-PEtOx obtained after thermal
treatment of FurMal-PEtOx, and (C) the Michael addition product of Mal-PEtOx with benzyl mercaptan (BzSMal-PEtOx). For a more extensive
assignment of the spectra, refer to Fig. S14.†
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View Article Onlinepopulation corresponding to the precursor polymer dis-
appeared and a new main population appeared with a shi of
approx. 62 amu (double charges), which matches perfectly with
the addition of a benzyl mercaptan molecule and proves that
the maleimide at the a end of the polymeric chain is reactive
(Fig. 3C and S14,† BzSMal-PEtOx). Two by-products can also be
observed and have so far not been identied. However, this
might be avoided with optimization of the Michael addition
conditions, which is not the subject of the current study. The
integrity of the polymer backbone during the successive trans-
formations could be conrmed by SEC, where no signicant
diﬀerence in the molar mass distributions of FurMal-PEtOx,
Mal-PEtOx, and BzSMal-PEtOx was observed (see Fig. S15;† Mn
¼ 6500–7000 g mol1, Đ ¼ 1.20–1.27).Bioconjugation
The therapeutic use of proteins and peptides is a rapidly
expanding area of research. One of its limitations, however, is
the delivery of protein-based drugs and other biologically active
proteins to their desired targets.34 Conjugation of PEG to
proteins – so-called PEGylation – has been a popular approach
to overcome these constraints and give the conjugates favorable
pharmacokinetic properties.46 However, due to the aforemen-
tioned issues related to PEG, the search for alternatives is vivid.
PAOx have been discussed as a promising option for stealth
polymers9 and, as such, can be used for “PAOxylation” of
proteins. Examples include the conjugation of PEtOx and
PMeOx to proteins such as catalase,47,48 bovine serum
albumin,48 ribonuclease,48 uricase,48 insulin,48 and granulocyte
colony stimulating factor.49This journal is © The Royal Society of Chemistry 2018Considering the relatively low abundance of cysteine in
natural proteins, maleimide-functionalized polymers call for
quasi-site-specic conjugation compared to the oen employed
coupling strategies making use of lysine residues. The thiol
addition to the activated double bond in aqueous conditions
works best at neutral or mild alkaline pH (7.5–8.5).50 A conju-
gation experiment was performed to attach the functional Mal-
PEtOx (Mn,NMR ¼ 6100 g mol1) to bovine serum albumin (BSA).
BSA was chosen as a well-known model protein possessing one
free cysteine exposed at its surface (Cys-34 residue) and avail-
able for conjugation.51 The experiment was carried out over-
night with three diﬀerent polymer-to-protein molar ratios (5, 10,
and 15) in 100 mM phosphate buﬀer at pH 7.6. Under these pH
conditions the conjugation via the amino group of lysine is
avoided, ensuring only attachment to the free cysteine present
in BSA.52 A rst characterization was performed using SDS-
PAGE electrophoresis (Fig. 4A and B). All lanes corresponding
to the incubation of BSA with Mal-PEtOx (Fig. 4A, last three
lanes) show a rather similar shi in the protein signal towards
higher molar masses, which indicates successful attachment of
the polymer to the protein. The reason for the broadening of the
BSA band is related to the fact that only about 55 to 70 percents
of commercial BSA contain the free cysteine residue.34,51,53
Importantly, no shi occurred when non-deprotected FurMal-
PEtOx was incubated with BSA in identical conditions (Fig. 4A
and B, 4th lane from the le and green trace, respectively). To
further prove the formation of the bioconjugate, a preparative
chromatographic separation was carried out and a sample
collected at lower retention time than the BSA eluting time
(highest intensity considered) was analyzed by MALDI-ToFRSC Adv., 2018, 8, 9471–9479 | 9477
Fig. 4 Protein conjugation experiment in 100 mM phosphate buﬀer at pH 7.6 for 18 hours at room temperature using three diﬀerent [Mal-
PEtOx]/[BSA] ratios. (A) SDS-PAGE gel stained with Coomassie blue. (B) Intensity of the signals from each lane as a function of electrophoretic
mobility. (C) MALDI-ToF spectra of (top) BSA and (bottom) the fraction collected after preparative FPLC of the PEtOx-BSA conjugate [Mal-
PEtOx]/[BSA] 5 : 1.
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View Article Onlinemass spectrometry. The spectrum of the conjugate sample
(Fig. 3C, bottom) shows that the sample is a mixture of two
species. First, a signal corresponding to the mass of pure BSA is
observed, which was expected since not all BSA molecules
contain a free thiol available for conjugation. Satisfactorily,
a second population at higher m/z with a shi corresponding
approximately to the mass ofMal-PEtOx can be observed. It also
exhibits a signicantly broader distribution than the protein, as
expected from a synthetic polymer–protein conjugate.Conclusions
A novel, eﬃcient route for the synthesis of maleimide end-
functionalized poly(2-alkyl-2-oxazoline)s has been established
using a nosylate initiator bearing a maleimide moiety protected
in the form of a furan-based Diels–Alder adduct. While the
limited solubility of the initiator requires polymerization at
relatively low monomer concentrations, molar masses relevant
for bioconjugation and surface functionalization could be ob-
tained. Although the functionalized initiator route can lead to
the presence of non-maleimide functionalized chains via H
transfer, the combination of a straightforward synthesis with
the availability of the u chain end for further functionalization
makes this route particularly attractive for advanced application
in life sciences, for instance for the development of bifunctional
linkers for surface biofunctionalization or for the construction
of articial protein dimers, where in both cases excess, non-
reacted polymer can easily be removed.9478 | RSC Adv., 2018, 8, 9471–9479Conﬂicts of interest
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